{"id":10005,"date":"2025-02-18T10:59:59","date_gmt":"2025-02-18T09:59:59","guid":{"rendered":"https:\/\/syva.es\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/"},"modified":"2025-02-18T13:14:07","modified_gmt":"2025-02-18T12:14:07","slug":"syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france","status":"publish","type":"post","link":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/","title":{"rendered":"Syvazul\u00ae BTV3 re\u00e7oit l&rsquo;autorisation d&rsquo;utilisation d&rsquo;urgence en France"},"content":{"rendered":"<p><strong>L\u2019agence nationale du m\u00e9dicament v\u00e9t\u00e9rinaire fran\u00e7aise (ANMV) autorise \u00e0 son tour l\u2019utilisation de Syvazul\u00ae BTV 3 sur son territoire.<\/strong><\/p>\n<p><strong>Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6. <\/strong><\/p>\n<p>Cette proc\u00e9dure d\u2019utilisation d\u2019urgence et temporaire permet aux autorit\u00e9s de chaque pays europ\u00e9en de d\u00e9roger \u00e0 l\u2019autorisation de mise sur le march\u00e9 classique. Elle permet d\u2019agir rapidement face \u00e0 une maladie qui impacte fortement non seulement la <strong>sant\u00e9 et le bien-\u00eatre des animaux<\/strong>, mais aussi la <strong>situation financi\u00e8re et psychologique des \u00e9leveurs<\/strong>..<\/p>\n<p>L\u2019ANMV a estim\u00e9 que le dossier pr\u00e9sent\u00e9 comporte suffisamment de donn\u00e9es sur la <strong>s\u00e9curit\u00e9<\/strong>, la <strong>qualit\u00e9<\/strong> et l\u2019<strong>efficacit\u00e9<\/strong> du vaccin pour autoriser son <strong>utilisation chez les ovins.<\/strong><\/p>\n<p>Cette autorisation d\u2019utilisation d\u2019urgence est valable au niveau national. Rappelons toutefois que le 15 janvier 2025, le Comit\u00e9 des M\u00e9dicaments \u00e0 Usage V\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion positive recommandant l\u2019octroi d\u2019une autorisation de commercialisation au niveau europ\u00e9en pour <strong>Syvazul\u00ae BTV 3.<\/strong>.<\/p>\n<h5>La FCO, une menace pour toute l\u2019Europe<\/h5>\n<p>La <strong>fi\u00e8vre catarrhale ovine (FCO)<\/strong>, \u00e9galement connue sous le nom de Bluetongue (BTV), est une maladie virale transmise par des <strong>moucherons piqueurs appel\u00e9s Culico\u00efdes.<\/strong> La p\u00e9riode d\u2019activit\u00e9 maximale de ces moucherons s\u2019\u00e9tend de juin \u00e0 octobre. Elle affecte principalement les ruminants, notamment les ovins et les bovins. Elle n\u2019est pas contagieuse et n\u2019est pas transmissible aux humains.<\/p>\n<p>27 s\u00e9rotypes du virus sont actuellement identifi\u00e9s. Ils ne g\u00e9n\u00e8rent pas d\u2019immunit\u00e9 crois\u00e9e, ce qui veut dire qu\u2019un vaccin efficace contre un s\u00e9rotype ne le sera pas contre un autre.<\/p>\n<p>Plusieurs s\u00e9rotypes circulent actuellement en Europe : BTV-1, BTV-3, BTV-4, BTV-8 et BTV-12. La <strong>vaccination<\/strong> est le moyen le plus <strong>efficace<\/strong> pour contr\u00f4ler la maladie. Elle sera d\u2019autant plus efficace si elle est r\u00e9alis\u00e9e <strong>avant la p\u00e9riode d\u2019activit\u00e9 maximale <\/strong> des moucherons et sur <strong>des animaux en bonne sant\u00e9.<\/strong><\/p>\n<h5>A propos de Syvazul\u00ae BTV3<\/h5>\n<p><strong>Syvazul\u00ae BTV 3<\/strong> s\u2019administre chez les ovins en une seule injection de 2 ml par voie sous-cutan\u00e9e. Il est disponible en flacons de 80 ml (40 doses) et 200 ml (100 doses).<\/p>\n<p><strong>Pour plus d\u2019informations, consultez la <a href=\"https:\/\/syva.es\/fr\/producto\/syvazul-btv-3-suspension-injectable\/\">page produit sur notre site <\/a><\/strong><\/p>\n<h5>A PROPOS DE SYVA<\/h5>\n<p>Depuis sa cr\u00e9ation en 1941, l&rsquo;entreprise espagnole Laboratorios Syva s&rsquo;est engag\u00e9e dans la recherche scientifique et le d\u00e9veloppement pour innover et fournir des solutions efficaces au secteur de la sant\u00e9 animale. Cette capacit\u00e9 d&rsquo;adaptation motive sa strat\u00e9gie de croissance et le maintien d&rsquo;installations de bio-ing\u00e9nierie et de fabrication de pointe pour produire des vaccins, des anti-infectieux de premi\u00e8re intention et d&rsquo;autres m\u00e9dicaments essentiels pour la sant\u00e9 et le bien-\u00eatre des animaux, qui sont distribu\u00e9s dans pr\u00e8s de 70 pays \u00e0 travers le monde.<\/p>\n<p><strong>Contact presse<\/strong> : redaccion@syva.es<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6. <\/p>\n","protected":false},"author":4,"featured_media":9999,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":""},"categories":[790,2177,794,792,444,806],"tags":[2243,2148,2331,2242,2217,2146,2211,2126,2294],"class_list":["post-10005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bien-etre-animal","category-communique-de-presse","category-en-bref","category-entreprise","category-non-classifiee","category-syva-dans-le-monde","tag-btv3-fr","tag-engagement-pour-lenvironnement","tag-europe-fr","tag-fco-fievre-catarrhale-ovine","tag-maladie-emergente","tag-sante-animale","tag-usage-durgence","tag-vaccin","tag-vaccination-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Syvazul\u00ae BTV3 re\u00e7oit l&#039;autorisation d&#039;utilisation d&#039;urgence en France - Syva<\/title>\n<meta name=\"description\" content=\"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syvazul\u00ae BTV3 re\u00e7oit l&#039;autorisation d&#039;utilisation d&#039;urgence en France - Syva\" \/>\n<meta property=\"og:description\" content=\"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Syva\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T09:59:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-18T12:14:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1570\" \/>\n\t<meta property=\"og:image:height\" content=\"882\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Caroline De Siron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline De Siron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\"},\"author\":{\"name\":\"Caroline De Siron\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\"},\"headline\":\"Syvazul\u00ae BTV3 re\u00e7oit l&rsquo;autorisation d&rsquo;utilisation d&rsquo;urgence en France\",\"datePublished\":\"2025-02-18T09:59:59+00:00\",\"dateModified\":\"2025-02-18T12:14:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\"},\"wordCount\":536,\"publisher\":{\"@id\":\"https:\/\/syva.es\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg\",\"keywords\":[\"BTV3\",\"engagement pour l'environnement\",\"Europe\",\"FCO - fi\u00e8vre catarrhale ovine\",\"Maladie \u00e9mergente\",\"Sant\u00e9 animale\",\"usage d'urgence\",\"vaccin\",\"Vaccination\"],\"articleSection\":[\"Bien-\u00eatre animal\",\"Communiqu\u00e9 de Presse\",\"En bref\",\"Entreprise\",\"Non classifi\u00e9(e)\",\"Syva dans le monde\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\",\"url\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\",\"name\":\"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France - Syva\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg\",\"datePublished\":\"2025-02-18T09:59:59+00:00\",\"dateModified\":\"2025-02-18T12:14:07+00:00\",\"description\":\"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.\",\"breadcrumb\":{\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg\",\"width\":1570,\"height\":882},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/syva.es\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/syva.es\/fr\/#website\",\"url\":\"https:\/\/syva.es\/fr\/\",\"name\":\"Syva\",\"description\":\"Soluciones con sentido para la salud animal\",\"publisher\":{\"@id\":\"https:\/\/syva.es\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/syva.es\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/syva.es\/fr\/#organization\",\"name\":\"Syva\",\"url\":\"https:\/\/syva.es\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Syva\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\",\"name\":\"Caroline De Siron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"caption\":\"Caroline De Siron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France - Syva","description":"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/","og_locale":"fr_FR","og_type":"article","og_title":"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France - Syva","og_description":"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.","og_url":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/","og_site_name":"Syva","article_published_time":"2025-02-18T09:59:59+00:00","article_modified_time":"2025-02-18T12:14:07+00:00","og_image":[{"width":1570,"height":882,"url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg","type":"image\/jpeg"}],"author":"Caroline De Siron","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Caroline De Siron","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#article","isPartOf":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/"},"author":{"name":"Caroline De Siron","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052"},"headline":"Syvazul\u00ae BTV3 re\u00e7oit l&rsquo;autorisation d&rsquo;utilisation d&rsquo;urgence en France","datePublished":"2025-02-18T09:59:59+00:00","dateModified":"2025-02-18T12:14:07+00:00","mainEntityOfPage":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/"},"wordCount":536,"publisher":{"@id":"https:\/\/syva.es\/fr\/#organization"},"image":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg","keywords":["BTV3","engagement pour l'environnement","Europe","FCO - fi\u00e8vre catarrhale ovine","Maladie \u00e9mergente","Sant\u00e9 animale","usage d'urgence","vaccin","Vaccination"],"articleSection":["Bien-\u00eatre animal","Communiqu\u00e9 de Presse","En bref","Entreprise","Non classifi\u00e9(e)","Syva dans le monde"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/","url":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/","name":"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France - Syva","isPartOf":{"@id":"https:\/\/syva.es\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage"},"image":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg","datePublished":"2025-02-18T09:59:59+00:00","dateModified":"2025-02-18T12:14:07+00:00","description":"Alors que la France fait face simultan\u00e9ment \u00e0 des \u00e9pid\u00e9mies in\u00e9dites de maladies vectorielles \u2013 fi\u00e8vre catarrhale ovine (FCO) et maladie h\u00e9morragique \u00e9pizootique (MHE) \u2013 les autorit\u00e9s de la sant\u00e9 v\u00e9t\u00e9rinaire viennent d\u2019autoriser l\u2019utilisation d\u2019urgence du vaccin Syvazul\u00ae BTV 3 chez les ovins, en vertu de l\u2019article 110, paragraphe 2, du r\u00e8glement (UE) 2019\/6.","breadcrumb":{"@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#primaryimage","url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/02\/Illu-Autorizacion-Syvazul-BTV3-France-2025-02-18_10-38-13.jpg","width":1570,"height":882},{"@type":"BreadcrumbList","@id":"https:\/\/syva.es\/fr\/syvazul-btv3-recoit-lautorisation-dutilisation-durgence-en-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/syva.es\/fr\/"},{"@type":"ListItem","position":2,"name":"Syvazul\u00ae BTV3 re\u00e7oit l'autorisation d'utilisation d'urgence en France"}]},{"@type":"WebSite","@id":"https:\/\/syva.es\/fr\/#website","url":"https:\/\/syva.es\/fr\/","name":"Syva","description":"Soluciones con sentido para la salud animal","publisher":{"@id":"https:\/\/syva.es\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/syva.es\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/syva.es\/fr\/#organization","name":"Syva","url":"https:\/\/syva.es\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","width":512,"height":512,"caption":"Syva"},"image":{"@id":"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052","name":"Caroline De Siron","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","caption":"Caroline De Siron"}}]}},"modified_by":"Caroline De Siron","_links":{"self":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/comments?post=10005"}],"version-history":[{"count":1,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10005\/revisions"}],"predecessor-version":[{"id":10024,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10005\/revisions\/10024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/media\/9999"}],"wp:attachment":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/media?parent=10005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/categories?post=10005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/tags?post=10005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}